Skip to main content
Figure 3 | Lipids in Health and Disease

Figure 3

From: In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines

Figure 3

In vitro Candida efficacy studies. Candida was exposed for 48 h to different doses of Fungizone™, iCo-009 and iCo-010 (0, 15.6, 31.25, 62.5, 125 and 250 μg AmpB/L). A vehicle control with the same lipid composition as iCo-010 was also used at comparable volumes. Growth was normalized by the corresponding absorbance of the untreated Candida. The vehicle control showed no effect on Candida growth. (* p < 0.05 n = 6-12 independent experiments, each experiment includes eight replicates).

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X